Champions Oncology, Inc. (CSBR) Financials
CSBR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-01-31 | 26.8 million | 28.8 million |
2023-10-31 | 28.3 million | 28.2 million |
2023-07-31 | 29.9 million | 28.0 million |
2023-04-30 | 34.3 million | 29.7 million |
CSBR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-01-31 | -1.0 million | 379000 |
2023-10-31 | 436000 | 53000 |
2023-07-31 | -4.7 million | 423000 |
2023-04-30 | -1.5 million | 208000 |
CSBR Net Income
No data available :(
CSBR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-01-31 | 4.5 million | - | 7.7 million |
2023-10-31 | 5.5 million | - | 8.1 million |
2023-07-31 | 4.9 million | - | 8.4 million |
2023-04-30 | 10.1 million | - | 8.6 million |
CSBR Shares Outstanding
CSBR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-01-31 | 126000 | 2.2 million | 2.8 million | 1.8 million |
2023-10-31 | 153000 | 2.5 million | 2.6 million | 1.8 million |
2023-07-31 | 668000 | 2.8 million | 2.9 million | 1.7 million |
2023-04-30 | 760000 | 2.9 million | 2.7 million | 1.8 million |
CSBR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-01-31 | 12.0 million | 7.8 million |
2023-10-31 | 11.6 million | 6.6 million |
2023-07-31 | 12.6 million | 7.7 million |
2023-04-30 | 13.1 million | 7.3 million |
CSBR
Price: $4.80
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -8.55
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 67.7 million